Per Malmström
121 – 140 of 157
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
(
- Contribution to journal › Article
-
Mark
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550(
- Contribution to journal › Article
- 1999
-
Mark
Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictive value of P53, MDM-2, P21-expression, KI-67 for response to docetaxel or methotrexate-fluorouracil (MF) in advanced breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Predictive value c-erB-B2 expression for response to docetaxel (D) or methotrexate-fluorouracil (MF) in advanced breast cancer
(
- Contribution to journal › Published meeting abstract
- 1998
-
Mark
Urokinase plasminogen activator and flow cytometric S-phase fraction as prognostic indicators in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
A dose intensity study of epirubicin weekly for disseminated breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
-
Mark
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
(
- Contribution to journal › Article
-
Mark
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide : prognostic and therapeutic implications
(
- Contribution to journal › Article
-
Mark
Psychological profile related to malignant tumours of different histopathology
(
- Contribution to journal › Article
-
Mark
Attitude towards aggression and creative functioning in patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence
(
- Contribution to journal › Article
- 1997
-
Mark
Induction chemotherapy with versus without hormonal synchronisation in locally advanced breast cancer
(
- Contribution to journal › Article
-
Mark
SBU har fel om strålbehandling vid hjärntumör. Snar postoperativ terapi förlänger symtomfri tid
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 1995
-
Mark
A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung
(
- Contribution to journal › Article
-
Mark
CAVIAR : a tool to improve serial analysis of the 12-lead electrocardiogram
(
- Contribution to journal › Article
- 1993
-
Mark
MMM as second line treatment for advanced breast cancer. Evidence of cross-resistance with antracyclines
(
- Contribution to journal › Published meeting abstract
-
Mark
Reoperation for malignant astrocytomas : personal experience and a review of the literature
(
- Contribution to journal › Article
- 1992
-
Mark
Phase II study of tauromustine in malignant glioma
(
- Contribution to journal › Article